A clinical study on Baduanjin exercise alleviating bone pain and improving balance function in patients with primary osteoporosis

Not Applicable

• Conditions: Primary osteoporosis; Musculoskeletal Diseases; Osteoporosis, unspecified

• Registration Number: ISRCTN76945140
• Lead Sponsor: China Academy of Chinese Medical Sciences

Brief Summary

2023 Protocol article in https://pubmed.ncbi.nlm.nih.gov/37716968/ (added 18/09/2023)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-06-07
• Last Update Posted: 3 October 2023
• Study Completion: 2024-04-01

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 160

Inclusion Criteria

1. Primary osteoporosis: T-value of bone density measurement is less than or equal to -2.5
2. Female aged from 45 to 70 years old and female menopause time is greater than 2 years, which are met at the same time. Male aged from 50 to 70 years old
3. Visual analogue scale (VAS) is greater than or equal to 3 points
4. Willing to participate in the study

Exclusion Criteria

1. Lumbar fusion or severe degeneration hinders normal bone mineral density measurement and there are less than two continuous intact lumbar vertebrae that can be evaluated by dual-energy X-ray absorptiometry (DXA)
2. Patients with serious primary diseases such as cerebrovascular, digestive tract, and lung diseases, because these diseases’ clinical manifestations may interfere with the results of this study
3. Secondary osteoporosis, including rheumatoid arthritis, multiple myeloma, gout, malabsorption syndrome, systemic lupus erythematosus and metabolic diseases, such as diabetes, thyroid disease, Cushing's syndrome and other diseases
4. The patients take drugs that affect bone metabolism within 3 months before enrollment, such as bisphosphonates, glucocorticoids, calcitonin, anticonvulsant drugs, heparin and other drugs
5. Those with a history of severe mental illness or poor compliance
6. Allergic constitution
7. Those who have participated in other clinical trials within 3 months

Study & Design

• Study Type: Interventional
• Study Design: Not specified